Newsroom
Sorted by: Latest
-
Former Blue Bird CEO to Retire From Board
MACON, Ga.--(BUSINESS WIRE)--Blue Bird Corporation (Nasdaq: BLBD), the leader in electric and clean-emission school buses, today announced that Phil Horlock, former Chief Executive Officer and a member of the company’s Board of Directors, will be stepping down from the Board, effective immediately. Phil served as President & CEO of Blue Bird for more than 12 years, leading the organization through a period of transformative growth, operational excellence, and long-term value creation. Follo...
-
Verastem Oncology Provides Update on RAMP 203 Phase 1/2 Clinical Trial for Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that following evaluation of interim data from the RAMP 203 clinical trial in advanced KRAS G12C-mutated non-small cell lung cancer (NSCLC) it will discontinue the trial to focus resources on clinical development of VS-7375, an oral KRAS G12D (ON/OFF) inhibitor, in advanced NSCLC and other solid tumors. The...
-
lululemon Comments on Chip Wilson’s Notice to Nominate Director Candidates
VANCOUVER, British Columbia--(BUSINESS WIRE)--lululemon athletica inc. (NASDAQ:LULU) (“lululemon” or the “company”) today commented on Chip Wilson’s announcement that he has submitted a notice to nominate three director candidates to stand for election to the company’s Board at lululemon’s 2026 Annual Meeting of Shareholders: The lululemon Board of Directors and leadership team have engaged extensively and in good faith for many years with Mr. Wilson to understand his perspectives and communica...
-
PathoCare Holdings, Inc. Announces Private Third-Party Tendered Offer Reflecting a $1.75 Billion Valuation, Commencement of Independent Fairness Opinion, and Expansion of Proposed Capital Raise to $50 Million
HOUSTON--(BUSINESS WIRE)--PathoCare Holdings, Inc.—the parent company of medical diagnostics innovator PathoCare, LLC, a leader in Lab-on-a-Chip non-invasive Point-of-Care diagnostics—today announced that it has received a private, third-party tendered offer involving the secondary purchase of shares from existing shareholders, reflecting an implied company valuation of approximately $1.75 billion. The tendered offer represents a continuation of PathoCare Holdings’ capital markets evolution fol...
-
CTBC杯日台高校野球国際親善試合が無事閉幕
台北、台湾--(BUSINESS WIRE)--(ビジネスワイヤ) -- 「2025年CTBC日台高校野球国際親善試合」が12月27日に閉幕しました。新荘球場には冬の寒さにもかかわらず約1万5千人ものファンが詰めかけました。中国信託商業銀行(CTBC Bank)がスポンサーを務めた3日間にわたるこの大会には、台湾と日本が誇る高校野球強豪校4校が参加しました。最優秀選手賞(MOP)は後藤健選手、長山武蔵選手、蔡辰瀧選手、楊家源選手がそれぞれ受賞しています。 表彰式では、中華民国野球協会(CTBA)でバイスプレジデントを務めるジョージ・チャオ氏がジェフリー・クーJr会長に代わり、日本高等学校野球連盟(JHBF)の井本亘理事に記念プレートを贈呈しました。双方とも甲子園選抜チームと台湾のブラックパンサーカップチームの交流試合の拡大を目指し、長期的な協力関係を築くことを誓いました。 CTBCファイナンシャル・ホールディングで取締役会秘書役を務めるロジャー・カオ氏は、選手たちの確かな基本技術と、試合前に雨でぬれたグラウンドを力を合わせて整備した取り組みを称えました。コーチや選手たちも本大会での学...
-
Saba Capital Releases Presentation Detailing Why Edinburgh Worldwide Investment Trust PLC Shareholders Deserve a New Board of Directors
LONDON--(BUSINESS WIRE)--Saba Capital Management, L.P. (together with certain of its affiliates, “Saba” or “we”), the largest shareholder of Edinburgh Worldwide Investment Trust PLC (EWI:LSE) (“EWI” or the “Company”), today issued a presentation outlining the urgent need to replace the Company’s Board of Directors (the “Board”) with three new, independent directors who are committed to maximising long-term value for all EWI shareholders. The presentation can be viewed here. At the upcoming Gene...
-
Deadline Alert: Klarna Group plc (KLAR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming February 20, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Klarna Group plc (“Klarna” or the “Company”) (NYSE: KLAR) securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with the Company’s September 2025 initial public offering (the “IPO”). IF YOU SUFFERED A L...
-
Deadline Approaching: SLM Corporation (SLM) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming February 17, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased SLM Corporation a/k/a Sallie Mae (“SLM” or the “Company”) (NASDAQ: SLM) securities between July 25, 2025 and August 14, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SLM CORPORATION (SLM), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN...
-
2026 Future of Fitness Report: Experts from Coherent Solutions Turn Years of Fitness Industry Software Engineering Work Into a Guidebook on Future-proof Digital Transformation in Fitness
MINNEAPOLIS--(BUSINESS WIRE)--Coherent Solutions releases its 2026 Future of Fitness report, turning years of fitness tech work into a guide to digital value and member engagement....
-
Pharmaceutical Regulatory Affairs in Asia Training Course: Important Aspects of Gaining and Maintaining a Successful Marketing Authorisation (Mar 24th - Mar 26th, 2026) - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs in Asia Training Course (Mar 24th - Mar 26th, 2026)" training has been added to ResearchAndMarkets.com's offering. The pharmaceutical market in Asia is growing at a rapid pace and presents both opportunities and challenges to those wishing to work in the region. Rather than a single market, Asia is a collection of different markets, each with their own regulatory processes, although harmonisation exists within the ASEAN countries....